Telix buys radiopharmacy network for $230M up front to expand US capacity 

Aus­tralian ra­dio­phar­ma com­pa­ny Telix Phar­ma­ceu­ti­cals is ac­quir­ing ra­dioiso­tope man­u­fac­tur­er RLS Ra­dio­phar­ma­cies in an­oth­er move to ex­pand its pres­ence in the US.

Telix is bud­get­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.